What criteria do you use for induction chemotherapy in advanced head and neck cancers?
Even though we do not have the best data on the use of induction chemotherapy, what are current practices?
Is your practice different between HPV+ and HPV- disease?
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · University of Texas MD Anderson Cancer Center
Answered on
We were advocates of IC for patients felt to be at higher risk for DM in oropharynx cancer. We believed these were patients with N2b-N3 disease. However, the recent PARADIGM and DeCIDE trials were negative for a survival advantage for IC, so personally my enthusiasm for IC for advanced oropharynx ca...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · UCSF Medical Center
Answered on
Almost never. Maybe for T4b or N3 non-oropharynx pharyngeal cancers. We use it most routinely for metastatic nasopharyngeal cancer in an attempt to gain control over distant disease prior to local-regional consolidation. We use it for marginally resectable or unresectable sinonasal neuroendocrine tu...
Join for free or sign in to see the full answer